- Home
- AMWL vs CTNM Comparison
AMWL vs CTNM Comparison
Compare AMWL & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWL
- CTNM
- Stock Information
- Founded
- AMWL 2006
- CTNM 2009
- Country
- AMWL United States
- CTNM United States
- Employees
- AMWL N/A
- CTNM N/A
- Industry
- AMWL Retail: Computer Software & Peripheral Equipment
- CTNM
- Sector
- AMWL Technology
- CTNM
- Exchange
- AMWL Nasdaq
- CTNM Nasdaq
- Market Cap
- AMWL 121.9M
- CTNM 114.1M
- IPO Year
- AMWL 2020
- CTNM 2024
- Fundamental
- Price
- AMWL $6.88
- CTNM $3.87
- Analyst Decision
- AMWL Hold
- CTNM Strong Buy
- Analyst Count
- AMWL 6
- CTNM 4
- Target Price
- AMWL $10.00
- CTNM $23.75
- AVG Volume (30 Days)
- AMWL 58.2K
- CTNM 86.8K
- Earning Date
- AMWL 05-01-2025
- CTNM 05-16-2025
- Dividend Yield
- AMWL N/A
- CTNM N/A
- EPS Growth
- AMWL N/A
- CTNM N/A
- EPS
- AMWL N/A
- CTNM N/A
- Revenue
- AMWL $261,675,000.00
- CTNM N/A
- Revenue This Year
- AMWL $2.28
- CTNM N/A
- Revenue Next Year
- AMWL $10.06
- CTNM N/A
- P/E Ratio
- AMWL N/A
- CTNM N/A
- Revenue Growth
- AMWL 2.79
- CTNM N/A
- 52 Week Low
- AMWL $5.00
- CTNM $3.69
- 52 Week High
- AMWL $12.95
- CTNM $22.00
- Technical
- Relative Strength Index (RSI)
- AMWL 44.58
- CTNM N/A
- Support Level
- AMWL $6.42
- CTNM N/A
- Resistance Level
- AMWL $7.15
- CTNM N/A
- Average True Range (ATR)
- AMWL 0.61
- CTNM 0.00
- MACD
- AMWL 0.00
- CTNM 0.00
- Stochastic Oscillator
- AMWL 36.28
- CTNM 0.00
About AMWL American Well Corporation
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.